You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management
- 2. Health Check: Fantastico! Telix wins Brazilian assent for prostate cancer imaging agent
- 3. Rice statistician earns $1 million CPRIT award to advance AI-powered precision medicine for prostate cancer
- 4. Press Release Biocartis NV: Biocartis Announces Multiple Abstracts Demonstrating the Impact of Idylla™ in Oncology Diagnostics to be Presented at USCAP 2025 Annual Meeting
- 5. Spatial genomics reveals cholesterol metabolism as a key factor in colorectal cancer immunotherapy resistance
- 6. Corrigendum: The synergistic effects of pyrotinib combined with adriamycin on HER2-positive breast cancer
- 7. Breast cancer treatments linked to accelerated aging in survivors
- 8. ‘Colossally wasteful': Trump's cuts imperil medical research at Columbia
- 9. Newly identified bacterial protein helps design cancer drug delivery system
- 10. The lactylation modification of proteins plays a critical role in tumor progression
Last updated at 16:38 GMT
Hot News Makers
Health/Pharma Companies
-
32162.66
-
14249.60
-
11068.81
-
8482.90
-
8096.91
-
8064.95
-
6827.20
-
6416.51
-
6056.70
-
5295.75
Drugs, Treatments, Trials
-
45682.28
-
26804.66
-
21381.83
-
16605.49
-
15206.27
-
11019.57
-
8373.07
-
6926.55
-
6715.89
-
6636.15
Last updated at 16:10 GMT
